Aaron Schuchart, Chief Business Officer at Aeglea BioTherapeutics, Inc. (AGLE), sold 6,000 shares at $9.50 ($57K) on 2018-09-27, disclosed to the SEC on 2018-09-28.
Open-market sale of $57k AGLE by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.50 | 5,900 | $56K | 98.3% |
| 2 | $9.55 | 100 | $955 | 1.7% |
| Total | $9.50 avg | 6,000 | $57K | 100% |